PortfoliosLab logo

Nektar Therapeutics

NKTR
Equity · Currency in USD
Sector
Healthcare
Industry
Biotechnology
ISIN
US6402681083
CUSIP
640268108

NKTRPrice Chart


Chart placeholderClick Calculate to get results

NKTRPerformance

The chart shows the growth of $10,000 invested in Nektar Therapeutics on Jan 5, 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $16,890 for a total return of roughly 68.90%. All prices are adjusted for splits and dividends.


NKTR (Nektar Therapeutics)
Benchmark (S&P 500)

NKTRReturns in periods

Returns over 1 year are annualized

PeriodReturn
1M-7.73%
6M-18.66%
YTD-3.82%
1Y-1.57%
5Y4.16%
10Y12.18%

NKTRMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

NKTRSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Nektar Therapeutics Sharpe ratio is -0.10. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


NKTR (Nektar Therapeutics)
Benchmark (S&P 500)

NKTRDividends


Nektar Therapeutics doesn't pay dividends

NKTRDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


NKTR (Nektar Therapeutics)
Benchmark (S&P 500)

NKTRWorst Drawdowns

The table below shows the maximum drawdowns of the Nektar Therapeutics. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Nektar Therapeutics is 87.95%, recorded on Aug 19, 2021. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-87.95%Mar 9, 2018869Aug 19, 2021
-73.43%Oct 19, 2010277Nov 21, 2011757Nov 25, 20141034
-44.28%Dec 2, 2014183Aug 24, 201586Dec 24, 2015269
-40.29%Sep 8, 201699Jan 30, 201734Mar 20, 2017133
-36.82%Dec 30, 201537Feb 23, 2016111Aug 1, 2016148
-27.79%Apr 6, 201045Jun 8, 201086Oct 8, 2010131
-27.52%Mar 30, 201728May 9, 2017101Oct 2, 2017129
-15.89%Feb 2, 20186Feb 9, 20189Feb 23, 201815
-8.22%Nov 30, 20175Dec 6, 20171Dec 7, 20176
-7.59%Oct 5, 20176Oct 12, 201718Nov 7, 201724

NKTRVolatility Chart

Current Nektar Therapeutics volatility is 45.87%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


NKTR (Nektar Therapeutics)
Benchmark (S&P 500)

Portfolios with Nektar Therapeutics


Loading data...

More Tools for Nektar Therapeutics